Investor Stock List
Ranked #3,359 of 8,699 institutional investors

Defilade Capital Management, L.P.

Emeryville, CA

$566M
US stock portfolio at live prices · today −$4.1M (−0.71%)
Live prices, last trade 11:46 AM ET
Value at quarter end (Q3 2026)
$599M
Change from Q2 2026
−$148.1M (−19.83%)
Positions
28 · 7 new, 14 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$48.7M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
LLY 8.32%PFE 7.44%GILD 6.75%BMRN 6.48%AMGN 5.76%
StockSharesValue, live% of portfoliovs Q2 2026
LLY Eli Lilly and Company34,774$47.1M8.32%Reduced −11%
PFE Pfizer Inc.1,524,999$42.1M7.44%Reduced −14%
GILD Gilead Sciences, Inc.226,572$38.2M6.75%New
BMRN BioMarin Pharmaceutical Inc.601,922$36.7M6.48%Reduced −12%
AMGN Amgen Inc.74,079$32.6M5.76%New
ISRG Intuitive Surgical, Inc.71,860$29.2M5.16%New
SYK Stryker Corporation81,524$25.7M4.54%New
AXSM Axsome Therapeutics, Inc.175,371$22.9M4.05%New
VEEV Veeva Systems Inc.69,141$18.5M3.26%Reduced −71%
TMO Thermo Fisher Scientific Inc.26,469$18.0M3.17%Reduced −49%
COGT Cogent Biosciences, Inc.631,645$17.2M3.04%Added +61%
ORIC ORIC Pharmaceuticals, Inc.2,272,497$17.0M3.01%Added +117%
VERA Vera Therapeutics, Inc.652,377$16.8M2.96%New
AGIO Agios Pharmaceuticals, Inc.570,318$16.2M2.86%Added +4%
BSX Boston Scientific Corporation350,778$14.9M2.64%New
LRMR Larimar Therapeutics, Inc.4,934,439$14.8M2.62%Added +34%
SOLV Solventum Corporation165,673$14.2M2.51%Reduced −48%
OCUL Ocular Therapeutix, Inc.2,275,512$13.0M2.29%Added +53%
NVST Envista Holdings Corporation534,430$12.4M2.19%Reduced −26%
RVMD Revolution Medicines, Inc.71,186$11.6M2.04%Reduced −14%
ENOV Enovis Corporation399,651$10.3M1.82%Reduced −25%
OLMA Olema Oncology, Inc.1,440,157$10.3M1.81%Added +56%
EVMN Evommune Inc1,430,573$10.1M1.79%Added +80%
ICUI ICU Medical, Inc.54,435$9.5M1.67%Reduced −49%
PACS PACS Group, Inc.164,984$7.3M1.29%Reduced −24%
ELDN Eledon Pharmaceuticals, Inc.3,525,338$6.3M1.11%Unchanged
BDTX Black Diamond Therapeutics, Inc.1,770,948$2.4M0.43%Added +6%
MREO Mereo BioPharma Group plc7,558,756$2.0M0.36%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
INSM Insmed Incorporated281,838$41.1M
BAX Baxter International Inc.1,459,380$37.2M
ZBH Zimmer Biomet Holdings, Inc.317,426$32.3M
ABT Abbott Laboratories285,778$29.7M
PTCT PTC Therapeutics, Inc.433,699$25.1M
PODD Insulet Corporation176,932$24.4M
ELAN Elanco Animal Health Incorporated864,080$22.4M
GKOS Glaukos Corporation66,519$15.8M
LNTH Lantheus Holdings, Inc.132,662$13.6M
TFX Teleflex Incorporated80,118$13.2M
GMED Globus Medical, Inc.139,637$9.4M
STAA STAAR Surgical Company322,126$7.9M
TYRA Tyra Biosciences, Inc.376,870$7.6M
DNLI Denali Therapeutics Inc.391,866$7.3M